Genexol-PM works by disrupting the microtubule network within cancer cells. Microtubules are essential for cell division, and paclitaxel stabilizes these structures, preventing them from breaking down. This stabilization halts cell division and triggers apoptosis, or programmed cell death, in cancer cells.
